TABLE 2.
Adverse events experienced by more than one patient across all aerosol foam treatment groups
| ADVERSE EVENT | CAL/BD AEROSOL FOAM (n=100) | CAL AEROSOLFOAM (n=99) | BD AEROSOL FOAM (n=99) |
|---|---|---|---|
| Medication residue | 0 | 2 | 3 |
| Application-site pain | 1 | 1 | 1 |
| Hypersensitivity | 1 | 1 | 0 |
| Nasopharyngitis | 0 | 1 | 1 |
| Contusion | 1 | 0 | 1 |
| Vitamin D decreased | 1 | 0 | 1 |
| Bronchitis | 0 | 0 | 2 |
BD=betamethasone dipropionate 0.064%; Cal=calcipotriene 0.005%